Leadership in health care private equity since 1986

The Latest News

September 10, 2012

Exagen Completes $5.3M Financing to Develop New Diagnostics Products


Exagen Diagnostics Inc . said it raised $5.3 million to finance market expansion and development of near-term pipeline products. The commercial-stage company sells products for diagnosing and monitoring rheumatic diseases such as lupus.

Tullis Health Investors led the round. Other investors include Cottonwood Technology Fund, Epic Ventures , Mesa Verde Venture Partners and Sun Mountain Capital. 

Exagen is based in Albuquerque, N.M., with a laboratory in Vista, Calif.